Ionis Pharmaceuticals Inc (NASDAQ:IONS)

44.73
Delayed Data
As of 12:57pm ET
 -0.50 / -1.11%
Today’s Change
39.07
Today|||52-Week Range
65.51
-11.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.8B

Company Description

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Contact Information

Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2331

Employees

Shareholders

Mutual fund holders55.69%
Other institutional36.76%
Individual stakeholders0.86%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
Brett P. MoniaChief Operating Officer
Elizabeth L. HougenCFO, Principal Accounting Officer & SVP-Finance
C. Frank BennettSenior Vice President-Antisense Research
Sanjay BhanotChief Medical Officer